摘要 |
<p>The present invention demonstrates the important role of C/EBPe in innate immune response against pathogens. Specifically, the inventors showed that in the absence of functional C/EBPe, mice are severely impaired in their ability to clear S. aureus infection. Neutrophils are particularly affected, and susceptibility to S. aureus can be rectified by treatment with interferon-gamma (IFN-?). Importantly, increased activity of C/EBPe, either by induced overexpression of C/EBPE or by application of nicotinamide or an analog, derivative or salt thereof, dramatically enhances immune killing of S. aureus and leads to amelioration of infection.</p> |
申请人 |
CEDARS-SINAI MEDICAL CENTER;KOEFFLER, H., PHILLIP;LIU, GEORGE, Y.;THOENNISSEN, NILS;KYME, PIERRE;GOMBART, ADRIAN, F. |
发明人 |
KOEFFLER, H., PHILLIP;LIU, GEORGE, Y.;THOENNISSEN, NILS;KYME, PIERRE;GOMBART, ADRIAN, F. |